background
baicalein
bioflavon
present
dri
root
scutellaria
baicalensi
georgi
known
reduc
eotaxin
product
human
fibroblast
howev
report
antiasthma
activ
effect
airway
injuri
methodologyprincip
find
standard
experiment
asthma
model
male
balbc
mice
sensit
ovalbumin
ova
treat
baicalein
mgkg
ip
vehicl
control
either
prevent
use
ova
challeng
therapeut
use
altern
model
baicalein
administ
male
balbc
mice
given
either
intranas
featur
asthma
determin
estim
airway
hyperrespons
ahr
histopatholog
chang
biochem
assay
key
inflammatori
molecul
airway
injuri
determin
apoptot
assay
transmiss
electron
microscopi
assess
key
mitochondri
function
baicalein
treatment
reduc
ahr
inflamm
experiment
model
tgfb
subepitheli
fibrosi
goblet
cell
metaplasia
also
reduc
furthermor
baicalein
treatment
significantli
reduc
activ
featur
mitochondri
dysfunct
apoptosi
bronchial
epithelia
conclusionsignific
find
demonstr
baicalein
attenu
import
featur
asthma
possibl
reduct
airway
injuri
restor
mitochondri
function
asthma
associ
recruit
variou
inflammatori
cell
eosinophil
lymphocyt
airway
cell
releas
variou
reactiv
free
radic
creat
oxid
microenviron
airway
injur
structur
cell
airway
bronchial
epitheli
cell
repeat
allerg
inflamm
lead
irrevers
epitheli
injuri
caus
detach
ciliat
bronchial
epitheli
cell
basement
membran
support
view
epitheli
clump
found
sputum
creola
bodi
bronchoalveolar
lavag
bal
asthmat
patient
inflammatori
cell
th
lymphocyt
eosinophil
mast
cell
histor
occupi
center
stage
asthma
research
recent
report
highlight
critic
role
epitheli
stress
decid
immun
respons
within
lung
epitheli
injuri
consid
one
primari
pathogen
mechan
develop
variou
featur
allerg
asthma
interestingli
restor
mitochondri
function
airway
epithelia
suffici
reduc
acut
lung
injuri
indic
effici
mitochondria
maintain
epitheli
homeostasi
thu
viabil
lung
other
previous
demonstr
associ
mitochondri
structur
chang
bronchial
epithelia
asthma
proinflammatori
effect
mitochondri
dysfunct
thu
interest
explor
therapeut
agent
restor
mitochondri
function
mean
reduc
deleteri
effect
airway
epitheli
injuri
baicalein
bioflavon
compon
present
dri
root
scutellaria
baicalensi
georgi
describ
chines
pharmacopoeia
drug
possess
wide
rang
biolog
activ
antivir
antioxid
antiinflammatori
antithrombot
anticanc
effect
shown
inhibit
activ
implic
mitochondri
degrad
reticulocyt
also
reduc
eotaxin
product
cultur
human
fibroblast
stimul
combin
tnfa
though
suggest
baicalein
may
antiallerg
effect
base
invitro
studi
confirm
vivo
importantli
baicalein
reduc
neuron
injuri
inhibit
retin
epitheli
apoptosi
induc
hydrogen
peroxid
light
hypothes
baicalein
may
antiasthma
activ
determin
effect
baicalein
baic
asthma
featur
male
balbc
mice
sensit
challeng
ova
treat
differ
concentr
baic
onset
allergen
challeng
fig
determin
effect
baicalein
ahr
singl
chamber
plethysmographi
perform
see
materi
method
concentr
methacholin
mch
mice
develop
increas
enhanc
paus
penh
baselin
valu
mch
penh
determin
penh
index
airway
hyperrespons
directli
proport
airway
obstruct
end
allergen
challeng
ovaovaveh
group
allerg
control
mice
exhibit
develop
ahr
mice
develop
airway
obstruct
even
low
dose
methacholin
shampbsveh
normal
control
mice
model
baic
reduc
ahr
dose
depend
manner
optim
effect
dose
mgkg
fig
therefor
subsequ
experi
perform
use
mgkg
dose
unless
otherwis
indic
confirm
estim
ahr
time
invas
airway
mechan
consid
reliabl
confirm
baic
mgkg
treatment
ova
induc
mice
associ
signific
reduct
ahr
fig
determin
effect
baic
airway
inflamm
histopatholog
analysi
perform
section
stain
haematoxylin
eosin
stain
lung
section
shown
fig
ovaovaveh
mice
develop
perivascular
peribronchi
infiltr
inflammatori
cell
includ
eosinophil
compar
control
shampbsveh
mice
contrast
ovaovaba
mice
show
signific
reduct
inflamm
around
vessel
bronchi
confirm
object
inflamm
score
tabl
sinc
eotaxin
play
signific
role
migrat
eosinophil
airway
measur
level
lung
homogen
shown
tabl
eotaxin
level
significantli
higher
ovaovaveh
mice
compar
shampbsveh
mice
baic
treatment
reduc
eotaxin
level
significantli
compar
ovaovaveh
mice
increas
eotaxin
level
associ
increas
recruit
eosinophil
airway
ovaovaveh
mice
fig
baicalein
treatment
reduc
airway
eosinophilia
determin
effect
baic
th
cytokin
ige
measur
level
lung
tissu
ova
specif
ige
sera
shown
tabl
level
ova
specif
ige
increas
ovaovaveh
mice
compar
shampbsveh
mice
baic
treatment
associ
signific
reduct
cytokin
also
ova
specif
ige
tabl
addit
baic
treatment
significantli
increas
ova
specif
tabl
sinc
increas
measur
ifnc
level
lung
tissu
shown
tabl
ifnc
level
decreas
ova
ovaveh
mice
compar
shampbsveh
mice
howev
baic
treatment
allerg
mice
associ
signific
increas
ifnc
level
tabl
sinc
baicalein
appear
restor
balanc
alter
th
th
respons
allerg
inflam
lung
test
effect
baicalein
tolllik
receptor
protein
known
skew
th
respons
toward
th
th
respect
shown
tabl
found
increas
ovaovaveh
mice
compar
shampbsveh
mice
baic
treatment
allerg
mice
associ
signific
decreas
level
level
unchang
tabl
determin
effect
baic
airway
remodel
chang
determin
effect
baic
goblet
cell
metaplasia
subepitheli
fibrosi
determin
effect
baic
goblet
metaplasia
perform
period
acidschiff
stain
lung
section
shown
fig
ova
ovaveh
mice
display
increas
goblet
cell
metaplasia
baic
treatment
reduc
confirm
morphometr
analysi
shown
fig
dens
accumul
collagen
found
subepitheli
region
bronchi
also
around
vascular
region
allerg
control
mice
compar
normal
control
mice
interestingli
baic
treatment
significantli
reduc
collagen
deposit
bronchovascular
region
fig
confirm
morphometri
sinc
tgfb
import
develop
subepitheli
fibrosi
determin
effect
baic
level
express
tgfb
shown
fig
ovaova
veh
mice
show
signific
express
tgfb
especi
subepitheli
mesenchym
region
increas
level
lung
cytosol
rel
shampbsveh
mice
fig
iv
interestingli
baic
treatment
result
reduct
express
level
tgfb
lung
fig
iiv
sinc
baicalein
show
antiasthma
effect
prevent
model
want
test
efficaci
therapeut
model
determin
therapeut
effect
baicalein
asthma
administ
mice
develop
asthma
symptom
fig
sinc
allergen
exposur
like
continu
asthma
therapi
human
subject
ova
challeng
continu
baic
treatment
day
fig
ovasensit
challeng
mice
show
asthma
featur
mch
induc
ahr
airway
inflamm
day
ova
challeng
data
shown
baic
treatment
therefor
start
day
ova
challeng
continu
ova
challeng
therapeut
model
baic
treatment
reduc
ahr
well
infiltr
inflammatori
cell
bronchovascular
region
inflamm
score
fig
b
confirm
antiasthma
activ
baic
administ
mice
given
intranas
fig
expect
administr
led
signific
increas
ahr
infiltr
inflammatori
cell
bronchovascular
region
correspond
increas
inflamm
score
fig
c
howev
baic
administr
treat
mice
led
signific
reduct
ahr
airway
inflamm
fig
c
addit
mice
administ
also
show
increas
ahr
airway
inflamm
attenu
baic
fig
e
baicalein
inhibit
activ
potent
specif
metabolit
gener
high
concentr
mitochondri
degrad
reticulocyt
process
reticulocyt
matur
also
found
increas
bronchial
epithelia
human
asthmat
condit
mitochondri
dysfunct
seem
crucial
pathogenesi
variou
respiratori
diseas
includ
asthma
preferenti
util
linol
acid
la
produc
hydroxyoctadecaeno
acid
hode
also
minim
util
arachidon
acid
aa
produc
hydroxyeicosatetraeno
acid
hete
context
determin
effect
baicalein
mitochondri
dysfunct
airway
epitheli
injuri
first
measur
level
metabolit
shown
fig
b
ova
ovaveh
mice
increas
level
compar
shampbsveh
mice
howev
baic
treatment
significantli
reduc
level
metabolit
fig
b
determin
effect
baicalein
mitochondri
function
experiment
asthma
model
measur
cytochrom
c
oxidas
activ
normal
respect
citrat
synthas
activ
lung
mitochondria
result
indic
normal
cytochrom
c
oxidas
activ
decreas
ovaovaveh
mice
compar
shampbsveh
fig
also
reduct
complex
activ
lung
mitochondria
ovaovaveh
mice
addit
subunit
iii
found
predominantli
express
bronchi
shampbsveh
mice
found
significantli
decreas
ovaovaveh
mice
fig
high
express
subunit
iii
bronchial
epithelia
may
relat
vulner
inflammatori
insult
interestingli
baic
significantli
restor
activ
cytochrom
c
oxidas
complex
restor
express
subunit
iii
cytochrom
c
oxidas
fig
baic
restor
reduct
cytochrom
c
oxidas
activ
complex
activ
allerg
control
mice
analyz
cytochrom
c
level
caspas
activ
lung
cytosol
shown
fig
ovaovaveh
mice
show
increas
level
cytochrom
c
lung
cytosol
compar
shampbsveh
mice
howev
ovaovaba
mice
show
signific
reduct
cytochrom
c
cytosol
fig
addit
ovaovaveh
mice
also
increas
activ
caspas
caspas
treatment
baic
abl
decreas
enzymat
activ
fig
c
measur
oxid
stress
mean
analyz
mitochondri
dysfunct
use
reliabl
marker
lipid
peroxid
shown
fig
isoprostan
found
significantli
increas
ovaovaveh
mice
compar
shampbsveh
mice
significantli
reduc
baic
sinc
increas
cytochrom
c
stimul
intrins
apoptot
pathway
measur
level
marker
oxid
dna
damag
bal
fluid
supernat
found
increas
level
ovaovaveh
mice
compar
shampbsveh
mice
reduc
baic
treatment
fig
furthermor
perform
tunel
apoptosi
assay
lung
section
determin
apoptot
index
organ
shown
fig
g
ovaovaveh
mice
show
increas
apoptosi
especi
bronchial
epitheli
cell
howev
baic
treatment
show
signific
reduct
dna
fragment
fig
g
determin
effect
baic
morpholog
chang
mitochondria
bronchial
epithelium
perform
transmiss
electron
microscopi
shown
fig
ova
ovaveh
mice
show
maxim
mitochondri
damag
form
loss
disrupt
crista
swell
thin
outer
membran
howev
baic
treatment
significantli
restor
mitochondria
normal
architectur
fig
determin
effect
baicalein
airway
injuri
determin
featur
mitochondri
dysfunct
tunel
apoptot
assay
lung
section
treat
mice
treat
baic
shown
figur
baic
treatment
tabl
effect
baicalein
ifnc
ova
specif
ige
eotaxin
level
airway
inflamm
score
reduc
mediat
increas
level
lung
baic
mediat
reduct
level
associ
restor
mitochondri
function
demonstr
increas
complex
activ
cytochrom
c
oxidas
activ
lung
mitochondria
reduct
cytochrom
c
lung
cytosol
fig
addit
baic
treatment
reduc
caspas
activ
apoptosi
bronchial
epithelia
induc
administr
fig
earlier
believ
airway
inflamm
play
domin
role
asthma
pathogenesi
airway
epitheli
injuri
believ
downstream
product
airway
immun
cell
infiltr
thu
therapeut
strategi
focus
reduc
airway
inflamm
howev
recent
report
includ
suggest
mitochondri
dysfunct
epitheli
injuri
crucial
allerg
airway
inflammatori
diseas
asthma
addit
demonstr
epithelia
may
influenc
immun
statu
lung
also
strongli
suggest
differ
therapeut
approach
devis
focus
protect
vulner
airway
allergen
induc
injuri
studi
evalu
potenc
baicalein
reduc
airway
injuri
mitochondri
dysfunct
allevi
featur
allerg
asthma
use
allerg
model
th
cytokin
model
demonstr
efficaci
baicalein
prevent
airway
injuri
found
baicalein
amelior
mitochondri
dysfunct
reduc
airway
injuri
attenu
variou
featur
airway
inflamm
allerg
model
also
th
cytokin
model
found
baicalein
reduc
perivascular
peribronchi
infiltr
inflammatori
cell
bal
fluid
eosinophilia
eotaxin
lung
ova
specif
ige
level
sera
earlier
studi
show
baicalein
reduc
product
eotaxin
stromal
deriv
factor
well
known
chemoattract
properti
recruit
differ
type
leukocyt
eosinophil
vasculatur
interestingli
baicalein
inhibit
tnfa
induc
adhes
molecul
express
cultur
human
umbil
vein
endotheli
cell
studi
baicalein
treatment
allerg
mice
modul
th
th
respons
increas
ifnc
ova
specif
decreas
baicalein
treatment
ova
induc
mice
result
reduct
level
without
affect
level
similar
reduct
baicalein
report
neuron
addit
baicalein
reduc
level
metabolit
hode
hode
shown
import
variou
featur
inflamm
chemotact
stimul
leukocyt
activ
migrat
lymphocyt
consequ
modul
differ
proinflammatori
mediat
baicalein
might
explain
reduct
airway
inflamm
observ
studi
reduct
interest
asthmat
lung
sinc
metabolit
produc
larg
quantiti
reticulocyt
process
mitochondri
degener
evid
baicalein
treatment
associ
restor
mitochondri
function
increas
activ
cytochrom
c
oxidas
complex
mitochondri
ultrastructur
chang
asthmat
bronchial
epithelia
therefor
reduct
mitochondri
dysfunct
restor
ultra
structur
chang
baicalein
could
either
due
inhibit
indirect
mechan
reduct
lipid
peroxid
howev
sinc
baicalein
nonspecif
inhibitor
observ
effect
baicalein
may
due
inhibit
alon
also
found
baicalein
treatment
reduc
level
secretori
phospholipas
data
shown
known
proinflammatori
mediat
asthma
pathogenesi
whether
direct
indirect
effect
remain
studi
later
mitochondri
damag
commonli
associ
epitheli
injuri
respiratori
diseas
found
baicalein
reduc
dna
fragment
bronchial
epitheli
cell
oxid
dna
damag
antiapoptot
effect
baicalein
ova
induc
asthma
model
interest
known
baicalein
caus
apoptosi
variou
tumor
cell
contrast
antiapoptot
effect
baicalein
demonstr
normal
cell
variou
stress
condit
well
known
cancer
cell
evad
mitochondri
apoptot
mechan
deplet
mitochondria
shift
nonmitochondri
metabol
warburg
effect
specul
appar
anomali
may
relat
differ
howev
investig
requir
determin
effect
baicalein
primari
lung
epitheli
cell
epitheli
injuri
one
primari
pathogen
mechan
asthma
sinc
initi
airway
remodel
induc
variou
growth
factor
tgfb
shown
baicalein
antifibrot
properti
vitro
studi
studi
baicalein
reduc
express
tgfb
along
reduct
collagen
deposit
subepitheli
region
like
relat
inhibit
epitheli
injuri
prosurviv
effect
discuss
interestingli
baicalein
treatment
also
reduc
goblet
cell
metaplasia
import
aspect
obstruct
airway
diseas
like
chronic
bronchiti
fig
mechan
unclear
appear
direct
effect
sinc
baicalein
pretreat
induc
human
bronchial
epithelia
reduc
level
vitro
studi
level
mg
protein
uninduc
induc
vehicl
treat
induc
pretreat
mm
mm
mm
baicalein
respect
previous
implic
goblet
cell
metaplasia
sinc
baicalein
broad
spectrum
biolog
activ
exact
mechan
underli
antiasthma
activ
studi
clear
howev
inhibit
variou
proinflammatori
mediat
tgfb
reduct
metabolit
hode
hode
like
lead
reduct
bronchial
epitheli
injuri
consequ
airway
remodel
could
possibl
mechan
baicalein
reduc
asthma
featur
summari
baicalein
treatment
either
allerg
th
cytokin
induc
mice
reduc
airway
epitheli
injuri
amelior
mitochondri
dysfunct
variou
featur
airway
inflamm
mous
model
could
import
implic
develop
therapeut
strategi
toward
airway
injuri
asthma
anim
studi
perform
strict
accord
guidelin
provid
committe
purpos
control
supervis
experi
anim
cpcsea
anim
week
old
male
balbc
mice
obtain
nation
institut
nutrit
hyderabad
india
central
drug
research
institut
lucknow
maintain
csirinstitut
genom
integr
biolog
delhi
util
studi
protocol
approv
institut
anim
ethic
committe
csirinstitut
genom
integr
biolog
delhi
india
surgic
procedur
perform
sodium
pentobarbit
anesthesia
maximum
effort
taken
minimum
suffer
anim
two
experiment
model
ova
model
b
th
cytokin
model
ova
model
two
set
experi
dose
titrat
experi
day
ova
pb
consecut
describ
earlier
baicalein
dissolv
dimethyl
sulfoxid
vehicl
baic
veh
administ
intraperiton
ip
day
twice
day
ml
volum
per
dose
prevent
model
similar
dose
given
day
therapeut
model
figur
note
studi
use
high
dose
baicalein
mgkg
oral
without
advers
effect
use
two
differ
treatment
durat
demonstr
prevent
therapeut
effect
baicalein
importantli
observ
advers
effect
inflamm
loss
weight
etc
mice
mice
given
similar
dose
baicalein
similar
durat
data
shown
th
cytokin
model
mg
ml
carrierfre
recombin
murin
r
system
bsa
bsa
alon
instil
nasal
open
isofluraneanesthet
mous
twice
day
day
mice
treat
baic
veh
intraperiton
ip
twice
day
two
day
figur
ahr
measur
euthanasia
perform
day
airway
hyperrespons
ahr
methacholin
mch
determin
day
singl
chamber
bodi
plethysmographi
invas
instrument
describ
earlier
briefli
mous
taken
buxco
singl
chamber
acclimat
minut
baselin
record
measur
minut
mice
challeng
pb
differ
concentr
mch
aerosol
signal
record
inbuilt
softwar
buxco
determin
penh
valu
reliabl
balbc
mice
mch
partial
concentr
methacholin
requir
doubl
baselin
enhanc
paus
penh
calcul
confirm
find
noninvas
bodi
plethysmographi
respiratori
mechan
determin
mechan
ventil
flexiv
system
scireq
canada
previous
describ
briefli
anesthet
mice
intub
tracheostomi
ventil
computercontrol
ventil
airway
resist
differ
concentr
mch
estim
use
flexiv
system
scireq
integr
ventil
respiratori
mechan
tem
first
gener
bronchi
perform
briefli
lung
similarli
fix
use
combin
situ
whole
bodi
perfus
immers
fix
lung
dissect
use
dissect
microscop
select
first
gener
bronchi
slice
bronchi
process
stain
view
tem
experi
hematoxylin
eosin
stain
period
acid
stain
masson
trichrom
stain
perform
anoth
portion
lung
assess
inflammatori
chang
goblet
cell
metaplasia
subepitheli
fibrosi
respect
airway
mucin
content
collagen
deposit
determin
quantit
morphometri
describ
earlier
littl
modif
sacrific
bronchoalveolar
lavag
bal
mitochondria
isol
cytosol
separ
perform
lung
lung
tissu
homogen
use
sandwich
elisa
bd
bioscienc
ifnc
tgfb
r
system
eotaxin
uscn
life
scienc
result
express
picogram
normal
protein
concentr
ova
specif
ige
measur
describ
earlier
marker
lipid
peroxid
measur
lung
homogen
competit
elisa
result
express
mg
protein
marker
oxid
dna
damag
measur
bal
fluid
supernat
competit
elisa
result
express
ml
bal
fluid
supernat
total
cytochrom
c
oxidas
activ
lung
mitochondria
caspas
activ
cytochrom
c
level
lung
cytosol
perform
complex
activ
mitosci
usa
caspas
activ
biovis
usa
determin
per
manufactur
instruct
perform
describ
earlier
commerci
goat
polyclon
antibodi
cytochrom
c
oxidas
iii
tgfb
santa
cruz
biotechnolog
inc
primari
antibodi
hrp
conjug
antigoat
igg
secondari
antibodi
neg
control
experi
perform
use
either
gamma
globulin
isotyp
control
jackson
immunoresearch
laboratori
inc
omiss
primari
antibodi
termin
deoxynucleotidyl
transferas
dutp
nick
end
label
tunel
apoptot
assay
tunel
assay
apoptosi
perform
lung
tissu
section
use
situ
apoptosi
detect
kit
dead
end
calorimetr
tunel
system
promega
describ
earlier
bronchial
epitheli
cell
per
lung
section
examin
experiment
blind
investig
number
apoptot
cell
express
percentag
whole
epitheli
cell
popul
apoptot
index
determin
direct
effect
baicalein
mucin
express
cell
human
bronchial
epithelia
pretreat
vehicl
dmso
differ
concentr
baicalein
mm
mm
mm
hr
induct
without
ng
ml
hr
hr
induct
cell
harvest
level
elisa
determin
cell
lysat
uscn
life
scienc
china
data
express
mean
sem
unpair
student
test
anova
posthoc
correct
perform
calcul
statist
signific
set
p
